FibroBiologics, Inc. Common Stock (FBLG)
USD 2.01
(-6.51%)
USD 2.01
(-6.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -6.4 Million | -4.06 Million | -1.41 Million | -1.16 Million |
| Net Income | -16.48 Million | -5.12 Million | -1.58 Million | -1.16 Million |
| Depreciation & Amortization | 437 Thousand | 94 Thousand | - | - |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | 1.76 Million | 265 Thousand | - | - |
| Change in working capital | 493 Thousand | 307 Thousand | 172 Thousand | - |
| Other non-cash items | 9.88 Million | 842 Thousand | - | - |
| Investing Cash Flow | -495 Thousand | - | - | - |
| Investments in PPE | -495 Thousand | - | - | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | - | - | - |
| Financing Cash Flow | 13.79 Million | 5.92 Million | 1.81 Million | 1.16 Million |
| Debt repayment | -300 Thousand | -3.71 Million | -1.52 Million | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 16.13 Million | 2.15 Million | - | - |
| Other Financing Activities | -2.34 Million | 60 Thousand | 292 Thousand | 1.16 Million |
| Accounts receivables | - | - | - | - |
| Accounts payables | 141 Thousand | 525 Thousand | - | - |
| Inventory | - | - | - | - |
| Other working capital | 352 Thousand | 307 Thousand | 172 Thousand | - |
| Cash at beginning of period | 2.26 Million | 407 Thousand | - | - |
| Cash at end of period | 9.16 Million | 2.26 Million | 407 Thousand | - |
| Capital Expenditure | -495 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 6.89 Million | 1.85 Million | 407 Thousand | - |
| Free Cash Flow | -6.89 Million | -4.06 Million | -1.41 Million | -1.16 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 898 Thousand | -8.46 Million | -9.71 Million | -16.48 Million | -2.19 Million | -2.16 Million |
| Depreciation & Amortization | 140 Thousand | 137 Thousand | 130 Thousand | 437 Thousand | 112 Thousand | 99 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 578 Thousand | 525 Thousand | 432 Thousand | 1.76 Million | 437 Thousand | 448 Thousand |
| Change in working capital | 463 Thousand | 419 Thousand | 318 Thousand | 493 Thousand | 504 Thousand | -71 Thousand |
| Other non-cash items | -3.16 Million | 4.04 Million | 7.92 Million | 9.88 Million | - | 3000.00 |
| Investing Cash Flow | -66 Thousand | -8000.00 | -2000.00 | -495 Thousand | -413 Thousand | -24 Thousand |
| Investments in PPE | -66 Thousand | -8000.00 | -2000.00 | -495 Thousand | -413 Thousand | -24 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -172 Thousand | 3.27 Million | - | 13.79 Million | 940 Thousand | -1.71 Million |
| Debt repayment | -172 Thousand | -459 Thousand | - | -300 Thousand | - | -300 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 2.81 Million | - | 16.13 Million | - | - |
| Other Financing Activities | -172 Thousand | - | - | -2.34 Million | - | -2.32 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 394 Thousand | -141 Thousand | 275 Thousand | 141 Thousand | - | -23 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 463 Thousand | 560 Thousand | 318 Thousand | 352 Thousand | - | - |
| Cash at beginning of period | 8.15 Million | 9.16 Million | 10.76 Million | 2.26 Million | 11.37 Million | 14.74 Million |
| Cash at end of period | 5.97 Million | 8.15 Million | 9.16 Million | 9.16 Million | 10.76 Million | 11.37 Million |
| Capital Expenditure | -66 Thousand | -8000.00 | -2000.00 | -495 Thousand | -413 Thousand | -24 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.18 Million | -1 Million | -1.6 Million | 6.89 Million | -612 Thousand | -3.36 Million |
| Free Cash Flow | -2.01 Million | -4.28 Million | -1.6 Million | -6.89 Million | -1.55 Million | -1.64 Million |
605388
1088
BNAI
BOWFF
600161
STMRF